Insmed reported $20.87B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Cytokinetics USD 3.95B 846M Jun/2025
DBV Technologies USD 370M 113M Sep/2025
Dynavax Technologies USD 1.19B 421M Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
Insmed USD 19.09B 5.22B Jun/2025
Novartis USD 258.67B 24.42B Sep/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025